Mustang Bio, Inc. (MBIO) stock
MBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.38−0.01 (-2.56%)
Close on Nov 18, 2026Market cap $2.88MP/E –Yield –
Mustang Bio operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Mustang Bio's operating cash flow for the twelve months ending Jun 30, 2026 was -$4.51M. For fiscal 2025 it was -$5.26M. The highest annual figure on record is -$4.13M in fiscal 2016.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.26M | – |
| FY2024 | Dec 31, 2024 | -$11.41M | – |
| FY2023 | Dec 31, 2023 | -$49.48M | – |
| FY2022 | Dec 31, 2022 | -$65.07M | – |
| FY2021 | Dec 31, 2021 | -$53.67M | – |
| FY2020 | Dec 31, 2020 | -$37.32M | – |
| FY2019 | Dec 31, 2019 | -$33.58M | – |
| FY2018 | Dec 31, 2018 | -$19.24M | – |
| FY2017 | Dec 31, 2017 | -$12.95M | – |
| FY2016 | Dec 31, 2016 | -$4.13M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$967.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.01M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.72M | – |
| Q3 FY2025 | Sep 30, 2025 | -$818.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.34M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.39M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.00M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.76M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.34M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.32M | – |
| Q4 FY2023 | Dec 31, 2023 | -$7.25M | – |
| Q3 FY2023 | Sep 30, 2023 | -$12.02M | – |
| Q2 FY2023 | Jun 30, 2023 | -$12.39M | – |
| Q1 FY2023 | Mar 31, 2023 | -$17.81M | – |
| Q4 FY2022 | Dec 31, 2022 | -$15.29M | – |
| Q3 FY2022 | Sep 30, 2022 | -$15.91M | – |
| Q2 FY2022 | Jun 30, 2022 | -$17.58M | – |
| Q1 FY2022 | Mar 31, 2022 | -$16.29M | – |
| Q4 FY2021 | Dec 31, 2021 | -$14.70M | – |
| Q3 FY2021 | Sep 30, 2021 | -$11.29M | – |
| Q2 FY2021 | Jun 30, 2021 | -$12.10M | – |
| Q1 FY2021 | Mar 31, 2021 | -$15.58M | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.48M | – |
| Q3 FY2020 | Sep 30, 2020 | -$10.12M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.57M | – |
| Q1 FY2020 | Mar 31, 2020 | -$10.15M | – |
| Q4 FY2019 | Dec 31, 2019 | -$9.49M | – |
| Q3 FY2019 | Sep 30, 2019 | -$8.83M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.78M | – |
| Q1 FY2019 | Mar 31, 2019 | -$6.48M | – |
| Q4 FY2018 | Dec 31, 2018 | -$6.52M | – |
| Q3 FY2018 | Sep 30, 2018 | -$3.80M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.36M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.57M | – |
| Q4 FY2017 | Dec 31, 2017 | -$5.17M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.77M | – |
| Q2 FY2017 | Jun 30, 2017 | -$974.00K | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.04M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.26M | – |
| Q3 FY2016 | Sep 30, 2016 | -$565.00K | – |
See a number that looks wrong?